Context Testing for genetic risks for venous thromboembolism (VTE) is common, but the
safety and utility of such testing need review. Objectives To define rates of recurrent VTE …

Thrombophilia can be broadly defined as an increased tendency toward hypercoagulability
and venous thrombosis. There are several defined risk factors for thrombosis, and these are …

Background: The optimal duration of oral anticoagulant therapy in patients with deep venous
thrombosis (DVT) of the lower extremities remains uncertain. Objective: To assess whether …

This article discusses how we approach medical decision making in the treatment of the
various facets of the antiphospholipid syndrome (APS), including secondary prophylaxis in …

Objectives The aim of this work is to tempt to define the best indications for thrombophilia
testing in VTE in clinical practice. On behalf of the French Group for Haemostasis and …

Why men appear to have an increased risk of recurrent venous thrombosis compared with
women is unknown. In a cohort study of families with thrombophilia, lifetime risk of recurrent …

Article-at-a-Glance Background Oral anticoagulation with warfarin is an increasingly
common medical intervention. Despite its efficacy, warfarin is difficult to manage …

Peripheral arterial disease (PAD) affects about 27 million people in North America and
Europe, accounting for up to 413,000 hospitalizations per year with 88,000 hospitalizations …

BACKGROUND: This study was conducted to evaluate the effect of levonorgestrel-releasing
intrauterine devices (LNG-IUDs) on menorrhagia in patients receiving anticoagulant therapy …

There is uncertainty about risk heterogeneity for venous thromboembolism (VTE) in older
patients with advanced cancer and whether patients can be stratified according to VTE risk …